^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Liquid Trace™ Hematology

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
Twitter
GTC’s Liquid Trace Hematology is a pan-cancer highly sensitive test evaluating cfRNA and cfDNA providing highly informative data that can be used for diagnoses, evaluating the host immune response, and identifying biomarkers for predicting responses to various therapies.
Cancer:
Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
Gene:
ABL1 (ABL proto-oncogene 1), CREBBP (CREB binding protein), GNAS (GNAS Complex Locus), NF2 (Neurofibromin 2), SMC3 (Structural Maintenance Of Chromosomes 3)
Method:
Liquid biopsy / cfRNA / cfDNA